Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0239946 (
liver fibrosis
)
8,268
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Patients with infectious viral or toxic cirrhosis of the liver participated in complex clinical pathomorphological and molecular-genetic study aimed at the search for markers of predisposition to accelerated
liver fibrosis
, in which the xenobiotic biotransformation system is involved. The results demonstrate association between
CYP2D6
(1846G/A) genotype and rapid cirrhosis development and indicate the necessity of studying the mechanisms underlying this association.
...
PMID:Cytochrome P450 2D6 polymorphism is a molecular genetic marker of liver cirrhosis progression. 2280 53
To study the effect of Fuzheng Huayu recipe (FZHY) on five types of isozymes of cytochrome P450 (CYP450) of normal and
liver fibrosis
rats by using the cocktail probe method. Dimethylnitrosamine ( DMN) was injected to induce the
liver fibrosis
model. After the tail vein injection with Cocktail probe solutions prepared with five CYP450s probe substrates (phenacetin-CYP1A2, omeprazole-CYP2C9, tolbutamide-CYP2C19, dextromethorphan-
CYP2D6
, midazolam-CYP3A4), the plasma concentrations of the five probe substrates were determined by LC-MS/MS, and the pharmacokinetic parameters were calculated by PK solutions 2. After the oral administration with FZHY, normal rats given phenacetin, omeprazole, tolbutamide and dextromethorphan showed increase in AUC(0-t) and decrease in CL to varying degrees, indicating that FZHY obviously inhibited the activities of CYP1A2, CYP2C9, CYP2C19 and
CYP2D6
in normal rats, but with no obvious effect on the activity of CYP3A4. After the oral administration with FZHY,
liver fibrosis
rats treated with CYP2C9 showed the significant increase in AUC(0-t) and significant decrease in Vd, hut with no obvious changes in the pharmacokinetic parameters of other four types of prove substances, suggesting that FZHY could significantly inhibit the activity of CYP2C9 in rats but had no effect on the activities of CYP1A2, CYP2C19,
CYP2D6
and CYP3A4. The changes in the activity of CYP450 isozymes in
liver fibrosis
rats may be the reason for FZHY's different effects on CYP450 isozymes in normal and
liver fibrosis
rats.
...
PMID:[Effect of Fuzheng Huayu recipe on CYP450 isozymes in normal and liver fibrosis rats]. 2622 65
Autoimmune hepatitis (AIH) is a chronic liver disease mediated by immunity, and could lead to
liver fibrosis
and hepatocellular carcinoma. However, the mechanisms for breaking hepatic tolerance and driving AIH still remain elusive. We herein reported that the non-specific liver inflammation triggered by carbon tetrachloride (CCl
4
) recruited high numbers of CD4+T, CD8+T and B cells, and elevated the expression of proinflammaitory cytokines in Balb/c mice, further breaking liver tolerance and inducing autoimmune response, AIH inflammation and
liver fibrosis
in the presence of
CYP2D6
antigen mimicry. In contrast, adenovirus infection could not break liver tolerance and induce AIH in Balb/c mice even in the presence of
CYP2D6
antigen mimicry. These results suggested that genetic predisposition could determine liver tolerance in Balb/c mice. The chemical induced inflammation in the liver breaks tolerance and might be considered important for the initiation and development of AIH in Balb/c mice.
...
PMID:Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice. 3180 99